Mr. Lv
Address:
Economic & Technological Development Zone, Tianmen City, Hubei Province, Tianmen, Hubei, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2024
Business Range:
Chemicals, Health & Medicine
Management System Certification:
GMP
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Hubei Teyer Pharmaceutical Co., Ltd. Was registered and established in 2002, under the jurisdiction of Shanghai Zaiqi Biotechnology Co., Ltd. The company is located in the Economic Development Zone of Tianmen City, Hubei Province, 120 kilometers away from Wuhan, and one hour's drive to Wuhan Tianhe Airport. Covering an area of 26000 square meters. I t is a pharmaceutical enterprise that strictly ...
Hubei Teyer Pharmaceutical Co., Ltd. Was registered and established in 2002, under the jurisdiction of Shanghai Zaiqi Biotechnology Co., Ltd. The company is located in the Economic Development Zone of Tianmen City, Hubei Province, 120 kilometers away from Wuhan, and one hour's drive to Wuhan Tianhe Airport. Covering an area of 26000 square meters. I t is a pharmaceutical enterprise that strictly designs and implements management in accordance with GMP requirements, specializing in the production of chemical synthetic raw materials. The product process is mature, and the production plant and supporting equipment and facilities are complete. The main products include Ganciclovir, Valaciclovir hydrochloride, mycophenolate mofetil and other 10 products that have been jointly reviewed and approved with the preparation as "A", as well as advanced cosmetic intermediates. Pioneering research and development succeeded in the industrial production process of Valganciclovir hydrochloride, and obtained the patent certificate for synthetic invention; It is the first enterprise in China to develop and successfully use the industrial route to produce monoacetyl Ganciclovir. Sodium Lauryl Sulfoacetate acetate and other products are enriching our product line. The company's products meet the special requirements of Chinese Pharmacopoeia, American Pharmacopoeia, European Pharmacopoeia and customers for product quality.
The company has two GMP raw material synthesis workshops, independent clean areas, and complete inspection equipment. The company has established long-term and stable international and domestic business relationships, and the product quality has been highly praised by customers.
The company conscientiously abides by the Drug Administration Law of the China and organizes production in strict accordance with the Good Manufacturing Practice for Drugs. Relying on the concept of "innovation, quality, efficiency, execution, dedication, and responsibility", adhering to the business principle of "safety first, quality first", establishing a trustworthy image, creating a quality brand, and contributing to human health!
The company has two GMP raw material synthesis workshops, independent clean areas, and complete inspection equipment. The company has established long-term and stable international and domestic business relationships, and the product quality has been highly praised by customers.
The company conscientiously abides by the Drug Administration Law of the China and organizes production in strict accordance with the Good Manufacturing Practice for Drugs. Relying on the concept of "innovation, quality, efficiency, execution, dedication, and responsibility", adhering to the business principle of "safety first, quality first", establishing a trustworthy image, creating a quality brand, and contributing to human health!
International Commercial Terms(Incoterms):
FOB, CIF
Terms of Payment:
LC, T/T
Average Lead Time:
Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays
Export Year:
2022-05-01
Main Markets:
South America, Southeast Asia, Africa, Mid East
Factory Address:
Economic & Technological Development Zone, Tianmen City, Hubei Province, Tianmen, Hubei, China
R&D Capacity:
ODM, Own Brand()
No. of R&D Staff:
5-10 People
No. of Production Lines:
3
Annual Output Value:
US$10 Million - US$50 Million